The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases

被引:29
|
作者
Kiran, Tugce [1 ]
Demirkesen, Cuyan [1 ]
Eker, Candan [2 ]
Kumusoglu, Hakki [2 ]
Tuzuner, Nukhet [1 ]
机构
[1] Istanbul Univ, Dept Pathol, Cerrahpasa Med Fac, TR-34098 Istanbul, Turkey
[2] Medimiks Med Biotechnol, Res & Dev Lab, Istanbul, Turkey
关键词
IRF4; translocation; MUM1; Cutaneous lymphomas; CD30; ALCL; MUM1; LYMPHOMAS;
D O I
10.1016/j.leukres.2012.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Current laboratory technics, clinicopathologic findings cannot always reliably distinguish primary cutaneous CD30(+) lymphoproliferative disorders (LPD), such as lymphomatoid papulosis (LyP), primary cutaneous CD30(+) anaplastic large cell lymphoma (PCALCL), transformed mycosis fungoides (T-MF) and systemic ALK(-) anaplastic large cell lymphoma (ALCL) with skin involvement. We investigated the presence of IRF4 translocation with break apart DNA-FISH method of these entities according to the recent studies of Feldman et al. In our study group with 53 cases, the detection of IRF4 translocation had a specificity and positive predictive value for PCALCL of 100%. In contrast MUM1/IRF4 protein expression was distributed widely without any predictive value. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:396 / 400
页数:5
相关论文
共 50 条
  • [31] IRF4 TRANSLOCATIONS IN SKIN BIOPSIES HELP DIFFERENTIATE CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA FROM OTHER T-CELL LYMPHOPROLIFERATIVE DISORDERS
    Wada, D.
    Law, M.
    Hsi, E.
    DiCaudo, D.
    Ma, L.
    Lim, M.
    de Souza, A.
    Weenig, R.
    Comfere, N.
    Macon, W.
    Erickson, L.
    Ozsan, N.
    Dogan, A.
    Feldman, A.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (01) : 105 - 106
  • [32] IRF4 links antigen affinity to CD8+ T-cell metabolism
    Finlay, David
    IMMUNOLOGY AND CELL BIOLOGY, 2014, 92 (01): : 6 - 7
  • [33] Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 89 BL Patients in Japan
    Satou, Akira
    Asano, Naoko
    Kato, Seiichi
    Elsayed, Ahmed Ali
    Nakamura, Naoya
    Ohshima, Koichi
    Nakamura, Shigeo
    BLOOD, 2015, 126 (23)
  • [34] High expression of MUM1/IRF4 mRNA is associated with a shorter overall survival in patients with multiple myeloma.
    Heintel, D
    Zojer, N
    Strasser-Weippl, K
    Vesely, M
    Gisslinger, H
    Drach, J
    Gaiger, A
    Jäger, U
    Ludwig, H
    BLOOD, 2005, 106 (11) : 445A - 445A
  • [35] Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL) A Reappraisal of 88 BL Patients in Japan
    Satou, Akira
    Asano, Naoko
    Kato, Seiichi
    Elsayed, Ahmed A.
    Nakamura, Naoya
    Miyoshi, Hiroaki
    Ohshima, Koichi
    Nakamura, Shigeo
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (03) : 389 - 395
  • [36] MHC class II loss in diffuse large B-cell lymphoma is inversely correlated with MUM1/IRF4 expression
    Wilkinson, Sarah
    Fernandez, Diane
    Chan, Wing
    Gascoyne, Randy
    Campo, Elias
    Jaffe, Elaine
    Staudt, Louis
    Delabie, Jan
    Rosenwald, Andreas
    Rimsza, Lisa
    CANCER RESEARCH, 2009, 69
  • [37] Expression of MUM1/IRF4 correlates with clinical outcomes in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Lorek, J
    Cleveland, R
    Kampalath, B
    Abed, N
    Dimitrov, R
    Chang, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 251A - 252A
  • [38] Expression of MUM1/IRF4 correlates with clinical outcomes in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Lorek, J
    Cleveland, R
    Kampalath, B
    Abed, N
    Dimitrov, R
    Chang, C
    MODERN PATHOLOGY, 2002, 15 (01) : 251A - 252A
  • [39] Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
    Allan, J. M.
    Sunter, N. J.
    Bailey, J. R.
    Pettitt, A. R.
    Harris, R. J.
    Pepper, C.
    Fegan, C.
    Hall, A. G.
    Deignan, L.
    Bacon, C. M.
    Pointon, J. C.
    Houlston, R. S.
    Broderick, P.
    Mainou-Fowler, T.
    Jackson, G. H.
    Summerfield, G.
    Evans, P. A.
    Strefford, J. C.
    Parker, A.
    Oscier, D.
    Pratt, G.
    Allsup, D. J.
    LEUKEMIA, 2010, 24 (04) : 877 - 881
  • [40] Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
    J M Allan
    N J Sunter
    J R Bailey
    A R Pettitt
    R J Harris
    C Pepper
    C Fegan
    A G Hall
    L Deignan
    C M Bacon
    J C Pointon
    R S Houlston
    P Broderick
    T Mainou-Fowler
    G H Jackson
    G Summerfield
    P A Evans
    J C Strefford
    A Parker
    D Oscier
    G Pratt
    D J Allsup
    Leukemia, 2010, 24 : 877 - 881